Indaptus Therapeutics to Present at the 24th Annual H.C. Wainwright Global Investment Conference
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq:INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer will present a corporate overview at the 24th Annual H.C. Wainwright Global Investment Conference. The conference is being held on September 12 – 14 at the Lotte New York Palace Hotel.
Related news for (INDP)
- MoBot’s Stock Market Highlights – 06/23/25 07:00 AM
- MoBot’s Stock Market Highlights – 06/23/25 06:00 AM
- MoBot’s Stock Market Highlights – 06/23/25 05:00 AM
- Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants
- Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab